Evidence map›Paper›PMID 34187521›Full record

ArticleInfectious agents and cancer2021

Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma.

Shahrzad Shadabi, Nargess Delrish, Mehdi Norouzi, Maryam Ehteshami, Fariba Habibian-Sezavar, Samira Pourrezaei, Mobina Madihi, Mohammadreza Ostadali, Foruhar Akhgar, Ali Shayeghpour and 4 more

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Shahrzad ShadabiStudent Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
Nargess DelrishDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mehdi NorouziDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Maryam EhteshamiStudent Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
Fariba Habibian-SezavarBlood Transfusion Research Center, High Institute for Research & Education in Transfusion Medicine, Tehran, Iran.
Samira PourrezaeiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mobina MadihiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadreza OstadaliHematology-Oncology and Stem Cell Transplantation Research Center, Shariati Hospital Tehran University of Medical Sciences, Tehran, Iran.
Foruhar AkhgarBlood Transfusion Research Center, High Institute for Research & Education in Transfusion Medicine, Tehran, Iran.
Ali ShayeghpourStudent Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
Cobra Razavi PashabaygDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Sepehr AghajanianStudent Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
Sayed-Hamidreza MozhganiNon-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. hamidrezamozhgani@gmail.com.
Seyed-Mohammad JazayeriDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. jazayerism@sina.tums.ac.ir.
Tehran University of Medical Sciences · IRJahrom University of Medical Sciences · IRAlborz University of Medical SciencesHigh Institute for Education and Research in Transfusion Medicine · IRShariati Hospital · IR

Funding

National Institute for Medical Research Development 977505
6 · The paper itself

Abstract

backgroundHuman T-lymphotropic virus 1 (HTLV-1) infection may lead to the development of Adult T-cell leukemia/lymphoma (ATLL). To further elucidate the pathophysiology of this aggressive CD4+ T-cell malignancy, we have performed an integrated systems biology approach to analyze previous transcriptome datasets focusing on differentially expressed miRNAs (DEMs) in peripheral blood of ATLL patients.

methodsDatasets GSE28626, GSE31629, GSE11577 were used to identify ATLL-specific DEM signatures. The target genes of each identified miRNA were obtained to construct a protein-protein interactions network using STRING database. The target gene hubs were subjected to further analysis to demonstrate significantly enriched gene ontology terms and signaling pathways. Quantitative reverse transcription Polymerase Chain Reaction (RTqPCR) was performed on major genes in certain pathways identified by network analysis to highlight gene expression alterations.

resultsHigh-throughput in silico analysis revealed 9 DEMs hsa-let-7a, hsa-let-7g, hsa-mir-181b, hsa-mir-26b, hsa-mir-30c, hsa-mir-186, hsa-mir-10a, hsa-mir-30b, and hsa-let-7f between ATLL patients and healthy donors. Further analysis revealed the first 5 of DEMs were directly associated with previously identified pathways in the pathogenesis of HTLV-1. Network analysis demonstrated the involvement of target gene hubs in several signaling cascades, mainly in the MAPK pathway. RT-qPCR on human ATLL samples showed significant upregulation of EVI1, MKP1, PTPRR, and JNK gene vs healthy donors in MAPK/JNK pathway. DISCUSSION: The results highlighted the functional impact of a subset dysregulated microRNAs in ATLL on cellular gene expression and signal transduction pathways. Further studies are needed to identify novel biomarkers to obtain a comprehensive mapping of deregulated biological pathways in ATLL.

Indexed as

Adult T-cell leukemia/lymphomaGene expression analysisHTLV-1JNK pathwaySystems biology

Identifiers

PMID34187521
PMCPMC8244200
OpenAlexW3173640381

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.